AstraZeneca hopes to make clinical trial operations carbon-negative by 2030

AstraZeneca has big plans to become carbon-negative by 2030, including collecting human samples obtained in clinical trials.

The company is working with its collaborators, including sites and suppliers to ensure the entire chain footprint is compliant with the company’s ambition.